000 04054nam a22004575i 4500
001 978-1-4471-4132-7
003 DE-He213
005 20140220082804.0
007 cr nn 008mamaa
008 120914s2013 xxk| s |||| 0|eng d
020 _a9781447141327
_9978-1-4471-4132-7
024 7 _a10.1007/978-1-4471-4132-7
_2doi
050 4 _aRC681-688.2
072 7 _aMJD
_2bicssc
072 7 _aMED010000
_2bisacsh
082 0 4 _a616.12
_223
100 1 _aRajamannan, Nalini M.
_eeditor.
245 1 0 _aCardiac Valvular Medicine
_h[electronic resource] /
_cedited by Nalini M. Rajamannan.
264 1 _aLondon :
_bSpringer London :
_bImprint: Springer,
_c2013.
300 _aXIII, 254 p. 114 illus., 97 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1.Natural History of Aortic Valve Stenosis -- 2. Cardiovascular Risk Factors for Calcific Aortic Valve Disease -- 3.Bicuspid Aortic Valve Disease: From Bench to Bedside -- 4.Experimental Evidence for the Role of Atherosclerosis in Calcific Aortic Valve Disease -- 5.The Electrocardiogram as a Risk Predictor in Asymptomatic Aortic Stenosis -- 6.Exercise Testing in Aortic Stenosis and in Mitral Regurgitation -- 7. Detection of Calcium in the Aortic Valve by Non- Invasive Imaging -- 8.Assessment of Aortic Stenosis Severity:Determining Timing to Surgery -- 9.Balloon Aortic Valvuloplasty -- 10.Imaging for TAVI -- 11.Transcutaneous Aortic Valve Implantation -- 12.Role of statins in valvular heart disease: Rheumatic valve disease and bioprosthetic valves -- 13.Slowing the Progression of Aortic Stenosis – The Emerging Role of Bisphosphonates -- 14.LDL-Density-Theory:Implications for Future Clinical Trials -- 15.Infective Endocarditis: New Recommendations and Perspectives -- 16.Assessment and Timing to Intervention of Mitral Regurgitation -- 17. Biology of Mitral Valve Disease -- 18.Mitral Valve Devices -- 19.Anatomy and Pathology of Right-sided atrioventricular and semilunal valves -- 20.Mechanisms, Evaluation and Management of Tricuspid Regurgitation.
520 _aExperimental studies in the field of cardiac valve biology are now demonstrating that the cardiac valve disease process is an active biology with risk factors analogous to vascular risk factors.  Understanding the risk factors is also evolving rapidly, giving physicians and scientists insight into the cellular mechanisms and raising the possibility of treating these valve lesions with other options besides surgical valve repair. Our knowledge of right-sided valve lesions is also rapidly becoming important in the field of valvular medicine. Not only is the pathology different from left-sided valve lesions, but the hemodynamic compromise is more complex and difficult to treat in patients who develop tricuspid or pulmonic valve disease. Early diagnosis and careful management of this patient population is critical for long term outcomes in this patient population.   Cardiac Valvular Medicine represents an overview of the most recent science, clinical trials and new discoveries in the field of valvular heart disease. The editor has assembled a team of highly experienced contributors to provide a thorough translational understanding of the current and future treatments for this patient population. Cardiologists, internists, family practice physicians, cardiac surgeons and basic scientists will all find enormous benefit from this textbook.
650 0 _aMedicine.
650 0 _aInternal medicine.
650 0 _aCardiology.
650 0 _aHeart
_xSurgery.
650 1 4 _aMedicine & Public Health.
650 2 4 _aCardiology.
650 2 4 _aInternal Medicine.
650 2 4 _aCardiac Surgery.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781447141310
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4471-4132-7
912 _aZDB-2-SME
999 _c94551
_d94551